MY209060A - Pyrazole compounds and preparation thereof - Google Patents

Pyrazole compounds and preparation thereof

Info

Publication number
MY209060A
MY209060A MYPI2020003963A MYPI2020003963A MY209060A MY 209060 A MY209060 A MY 209060A MY PI2020003963 A MYPI2020003963 A MY PI2020003963A MY PI2020003963 A MYPI2020003963 A MY PI2020003963A MY 209060 A MY209060 A MY 209060A
Authority
MY
Malaysia
Prior art keywords
preparation
alkyl
pyrazole compounds
haloalkyl
independently selected
Prior art date
Application number
MYPI2020003963A
Other languages
English (en)
Inventor
Sunil Sharma
Dinesh Jangid
Priyanka Dhaka
Siddharth Madhwal
Bharat Kumar
Kapil Kumar
Rajdeep Anand
Anurag Jain
Original Assignee
Myokardia Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Myokardia Inc filed Critical Myokardia Inc
Publication of MY209060A publication Critical patent/MY209060A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J23/00Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
    • B01J23/70Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of the iron group metals or copper
    • B01J23/72Copper
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J27/00Catalysts comprising the elements or compounds of halogens, sulfur, selenium, tellurium, phosphorus or nitrogen; Catalysts comprising carbon compounds
    • B01J27/06Halogens; Compounds thereof
    • B01J27/08Halides
    • B01J27/122Halides of copper
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18One oxygen or sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials Engineering (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
MYPI2020003963A 2018-02-01 2019-02-01 Pyrazole compounds and preparation thereof MY209060A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN201811003855 2018-02-01
IN201811003859 2018-02-01
IN201711042921 2018-05-30
PCT/IN2019/050076 WO2019150392A1 (en) 2018-02-01 2019-02-01 Pyrazole compounds and preparation thereof

Publications (1)

Publication Number Publication Date
MY209060A true MY209060A (en) 2025-06-18

Family

ID=67478207

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2020003963A MY209060A (en) 2018-02-01 2019-02-01 Pyrazole compounds and preparation thereof

Country Status (14)

Country Link
US (1) US11873289B2 (https=)
EP (1) EP3746434A4 (https=)
JP (1) JP7402804B2 (https=)
KR (1) KR102951622B1 (https=)
CN (1) CN111670184A (https=)
AU (1) AU2019213854C1 (https=)
BR (1) BR112020015692A2 (https=)
CA (1) CA3090204A1 (https=)
IL (1) IL276410B2 (https=)
MA (1) MA54677A (https=)
MX (2) MX2020008151A (https=)
MY (1) MY209060A (https=)
SG (1) SG11202007328UA (https=)
WO (1) WO2019150392A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3090204A1 (en) 2018-02-01 2019-08-08 MyoKardia, Inc. Pyrazole compounds and preparation thereof
WO2025244956A1 (en) * 2024-05-20 2025-11-27 MyoKardia, Inc. Methods of manufacturing danicamtiv

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007284386A (ja) * 2006-04-18 2007-11-01 Kumiai Chem Ind Co Ltd 3−ピラゾリルフェニルスルフィド誘導体及びそれを有効成分として含有する殺虫・殺ダニ・殺線虫剤
US8324178B2 (en) * 2008-10-31 2012-12-04 The Regents Of The University Of California Method of treatment using alpha-1-adrenergic agonist compounds
EP2714680B1 (en) * 2011-05-27 2015-11-25 Amira Pharmaceuticals, Inc. Heterocyclic autotaxin inhibitors and uses thereof
BR112015004097B1 (pt) 2012-08-30 2020-02-18 Bayer Cropscience Ag Procedimento para a descarboxilação de derivados do ácido 3,5-bis (haloalquil) -pirazol-4-carboxílico
CN104968664A (zh) 2012-12-12 2015-10-07 山东亨利医药科技有限责任公司 作为酪氨酸激酶抑制剂的并环化合物
EP3063134B1 (en) 2013-11-01 2020-08-12 Srf Limited Process for the preparation of pyrazole derivatives
EP3015458A1 (en) 2014-11-03 2016-05-04 Bayer CropScience AG Process for preparing 3,5-bis(haloalkyl)pyrazole derivatives from a,a-dihaloamines and ketimines
EP4234017B1 (en) * 2015-01-22 2026-04-15 MyoKardia, Inc. Preparation of 4-methylsulfonyl-substituted piperidine urea compounds useful for the treatment of cardiac disorders such as dilated cardiomyopathy (dcm)
EP3568390B1 (en) * 2017-01-10 2024-03-06 Sanford Burnham Prebys Medical Discovery Institute Small molecule activators of nicotinamide phosphoribosyltransferase (nampt) and uses thereof
CN111132964A (zh) 2017-04-11 2020-05-08 欧瑞克制药公司 糖皮质激素受体调节剂
CA3090204A1 (en) 2018-02-01 2019-08-08 MyoKardia, Inc. Pyrazole compounds and preparation thereof

Also Published As

Publication number Publication date
EP3746434A1 (en) 2020-12-09
IL276410B2 (en) 2024-09-01
IL276410A (en) 2020-09-30
MX2020008151A (es) 2020-09-18
US11873289B2 (en) 2024-01-16
KR102951622B1 (ko) 2026-04-13
AU2019213854C1 (en) 2023-12-14
US20210053940A1 (en) 2021-02-25
SG11202007328UA (en) 2020-08-28
MX2025003379A (es) 2025-05-02
MA54677A (fr) 2021-11-17
KR20200118025A (ko) 2020-10-14
CA3090204A1 (en) 2019-08-08
EP3746434A4 (en) 2021-11-17
AU2019213854B2 (en) 2023-06-15
JP7402804B2 (ja) 2023-12-21
CN111670184A (zh) 2020-09-15
JP2021512127A (ja) 2021-05-13
AU2019213854A1 (en) 2020-09-03
BR112020015692A2 (pt) 2020-12-08
WO2019150392A1 (en) 2019-08-08
IL276410B1 (en) 2024-05-01

Similar Documents

Publication Publication Date Title
WO2015104698A3 (en) Combination of novel nitrification inhibitors and biopesticides as well as combination of (thio)phosphoric acid triamides and biopesticides
PH12014502866A1 (en) Fungicidal heterocyclic carboxamides
TW200626559A (en) Anilino-pyrimidine analogs
PH12016502154B1 (en) Pyridazinone herbicides
PH12014502117B1 (en) Tetrazolinone compounds and its use as pesticides
MX2009008772A (es) Derivado piridil-triazolopirimidina o su sal, pesticida que lo contiene y proceso para su produccion.
MX2016006685A (es) Compuestos heterociclicos de n-acilimino.
MY161134A (en) Piperazine compound having a pgds inhibitory effect
WO2015104700A3 (en) Combination of novel nitrification inhibitors and insecticides and/or nematicides as well as combination of (thio)phosphoric acid triamides and insecticides and/or nematicides
PH12017501652A1 (en) Kv1.3 inhibitors and their medical application
PH12020550592A1 (en) Process for producing herbicidal pyridazinone compounds
AR106522A1 (es) Intermediarios para preparar herbicidas de piridazinona, y un proceso para prepararlos
JOP20200326A1 (ar) مشتقات تترا هيدرو ثينوبيريدين بها استبدال بـ n واستخداماتها
MY160882A (en) Biocidal composition and method
MX2019000035A (es) Composicion de amina util para producir espuma de poliuretano.
MY209060A (en) Pyrazole compounds and preparation thereof
PH12018500066A1 (en) Pyridine compounds
MX2016003630A (es) Compuestos heterociclicos de n-acilimino.
PH12021551849A1 (en) Internal cyclic sulphiamidine amide-aryl amide compound and use thereof for treating hepatitis b
EA202091842A1 (ru) Пиразольные соединения и их получение
MY195906A (en) Novel Bisphosphonic Acid Compound
MX2007007256A (es) Cetonas de piridina con efecto herbicida.
PH12017501653B1 (en) Kv1.3 inhibitors and their medical application
TW200716521A (en) Substituted aryl oximes
ZA202102657B (en) Synthesis of 1,1,2-trifluoro-4-(substituted sufonyl)-but-1-ene